Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients

Clinical trial NCT07245069 · RECRUITING

Trial details

NCT number: NCT07245069
Sponsor: University Medical Centre Ljubljana
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Heart Failure Anthracycline-induced Cardiac Toxicity Endothelial Function (FMD)Arterial Stiffness Breast Cancer

Start date: 2025-02-01
Primary completion: 2028-11-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.